ARCHIVES

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Las Vegas Cancer Center Cuts Staff, Seeks Lifelines During “Perfect Storm”

May 20, 2011

In Brief: Howard Skipper Retires; Oglesby To Head SRI; John Montgomery Named Kettering-Meyer Director

December 19, 1980

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

Reader Finds Letter insulting to Ethic Group

February 16, 1996

Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices

June 26, 1992